Pharmafile Logo

Frontera London

EU flag

EC approves Bavarian Nordic’s mpox vaccine Imvanex for use in adolescents

More than 120 countries have confirmed over 103,000 cases of mpox since the global outbreak began in 2022

- PMLiVE

Sanofi shares positive late-stage results for investigational BTK inhibitor in progressive MS

Tolebrutinib is currently being evaluated in various forms of the neurological disorder

- PMLiVE

Wedgewood appoints Danielle Cranwell as president and global agency head

Cranwell most recently served as executive vice president, managing partner at Biolumina

- PMLiVE

Seeing giraffes in the boardroom

Why strategy sometimes needs a nudge

- PMLiVE

Novo Nordisk and NanoVation to develop genetic medicines in partnership worth $600m

The companies will collaborate on up to seven programmes for cardiometabolic and rare diseases

- PMLiVE

Merck/Daiichi Sankyo’s ADC candidate shows promise in phase 3 lung cancer trial

EGFR-activating mutations occur in up to 38% of all NSCLC tumours globally

- PMLiVE

ICR researchers identify new drug target for advanced prostate cancer patients

The team estimates that around 10% of patients have high levels of the BCL2 protein

- PMLiVE

FlyPharma Europe to return to Vienna in October

The conference will take place at Vienna AirportCity on 23 to 24 October 2024

- PMLiVE

Laying the groundwork for rare disease therapies

Addressing the challenges of convincing payers that the therapy meets an unmet need

- PMLiVE

Unlock the Future of Medical Publications—Next Week!

Dive into a comprehensive exploration of the latest trends and cutting-edge strategies in medical publication planning. Our exclusive webinar series, starting next week, offers a deep dive into the intricacies...

Impetus Digital

- PMLiVE

Innovative Trials’ CEO wins Women in Pharma Award

Kate Shaw, founder and CEO of Innovative Trials, a global clinical trial patient recruitment and retention company, won the ‘Woman in Pharma’ at the Pharma Industry Awards UK. She was...

Innovative Trials

- PMLiVE

Where did “KOLs” come from, and why do they matter?

Ever wondered where 'KOLs' came from and why they matter? Dr Alex Loveday answers those questions in this latest edition of her column.

Mednet

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links